NR-9490_单克隆抗流感病毒H9血凝素(HA)蛋白(1073-9),A/HongKong/1073/1999(H9N2),(腹水,小鼠)(单克隆抗体）
产品图片
货号/SKU
NR-9490
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、1
产品描述信息
NR-9490?? Monoclonal Anti-Influenza Virus H9 Hemagglutinin (HA) Protein (1073-9), A/Hong Kong/1073/1999 (H9N2), (ascites, Mouse)(Monoclonal Antibodies)|Influenza A virus|Monoclonal Anti-Influenza Virus H9 Hemagglutinin (HA) Protein (1073-9), A/Hong Kong/1073/1999 (H9N2), (ascites, Mouse)|-20°C to -40°C|St. Jude Children's Research Hospital (CEIRS)Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Monoclonal Anti-Influenza Virus H9 Hemagglutinin (HA) Protein (1073-9), A/Hong Kong/1073/1999 (H9N2), (ascites, Mouse), NR-9490."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Antibody Class: IgG1.κ, IgM.κ
Note: The hybridoma used to prepare this preparation may not be monoclonal and/or the preparation may contain endogenous murine immunoglobulin.
Mouse antibody (1073-9) specific to a recombinant form of the H9 hemagglutinin (HA) protein (GenPept: CAB95856) of the A /Hong Kong/1073/1999 (H9N2) strain of influenza virus was produced in mouse ascites.
NR-9490 is specific for the H9 HA subtype of the influenza A virus as determined in standard hemagglutination inhibition (HI) assays. NR-9490 also demonstrates reactivity within the H9 HA subtype. HI titers with 20 different influenza strains of the H9 HA subtype representing Eurasian and North America lineages, as well as H9 HA viruses from other geographic areas, are shown on the Certificate of Analysis. No reactivity was observed with several viruses of North American lineage.
Each vial of NR-9490 contains lyophilized (1.0 mL containing 0.02% sodium azide and 0.01% gentamycin) mouse ascites fluid
Antibody Class: IgG1.κ, IgM.κ
Note: The hybridoma used to prepare this preparation may not be monoclonal and/or the preparation may contain endogenous murine immunoglobulin.
Mouse antibody (1073-9) specific to a recombinant form of the H9 hemagglutinin (HA) protein (GenPept: CAB95856) of the A /Hong Kong/1073/1999 (H9N2) strain of influenza virus was produced in mouse ascites.
NR-9490 is specific for the H9 HA subtype of the influenza A virus as determined in standard hemagglutination inhibition (HI) assays. NR-9490 also demonstrates reactivity within the H9 HA subtype. HI titers with 20 different influenza strains of the H9 HA subtype representing Eurasian and North America lineages, as well as H9 HA viruses from other geographic areas, are shown on the Certificate of Analysis. No reactivity was observed with several viruses of North American lineage.
Each vial of NR-9490 contains lyophilized (1.0 mL containing 0.02% sodium azide and 0.01% gentamycin) mouse ascites fluid
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送到NIAID进行批准. 抗体类：Igg1.κ，IgM.κ 注意：用于制备该制剂的杂交瘤可能不是单克隆和/或制剂可含有内源小鼠免疫球蛋白. 小鼠抗体（1073-9）特异于重组形式A / Hong Kong / 1073/1999（H9N2）流感病毒菌株的H9 Hemagglutinin（HA）蛋白（Genpept：Cab95856）在小鼠腹水中产生. NR-9490特定于H9 HA按标准血凝抑制（HI）测定中测定的流感病毒的亚型. NR-9490还证明了H9 HA亚型内的反应性. HI滴度具有20种不同的流感菌株的H9 HA亚型，代表欧亚和北美谱系，以及来自其他地理区域的H9 HA病毒，显示在分析证书上.没有用几种北美血管病毒观察到反应性. 每个小瓶NR-9490含有冻干（1.0ml含有0.02％叠氮化钠和0.01％庆大霉素）小鼠腹水液
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-03-31
2022-04-01
2021-12-21
2021-12-13
2021-12-21
2024-05-19
2022-04-01
2024-05-19
2021-12-02
2022-04-01
2024-05-19
2022-04-01
2019-05-08
2021-12-21
2024-06-03